staurosporine has been researched along with Cardiac Remodeling, Ventricular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boivin, MN; Bouchentouf, M; Boulassel, MR; Cuerquis, J; Forner, KA; Galipeau, J; Paradis, P; Routy, JP; Schiffrin, EL; Zheng, J | 1 |
1 other study(ies) available for staurosporine and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction.
Topics: Animals; Apoptosis; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Endothelial Cells; Female; Flow Cytometry; Hepatocyte Growth Factor; Humans; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Monocytes; Muscle Cells; Myocardial Infarction; Neovascularization, Physiologic; Receptors, Tumor Necrosis Factor, Type I; Staurosporine; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |